QHSLab, Inc. Stock

USAQ

US90350R1077

Advanced Medical Equipment & Technology

Market Closed - OTC Markets Other stock markets 03:49:24 12/06/26 am AEST			5-day change	1st Jan Change
0.2500 ^USD	-17.36%		-44.51%	-58.74%

14/05	QHSLab, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
21/04	QHSLab Launches Q-Connect Glp-1 Support Assessment	CI

on all subscriptions*

Last days

Enjoy this offer

* See conditions under "Our services"

QHSLab, Inc. is a medical device technology and software as a service (SaaS) company focused on primary care physicians (PCPs) and other healthcare providers to offer tools to evaluate and treat chronic diseases as well as provide preventive care through reimbursable procedures. Its Quality Health System Lab Expert System (QHSLab), a digital healthcare platform, provides clinical decision support and point of care solutions and supports non-face-to-face remote patient and therapeutic monitoring, to address chronic care and preventive medicine and is reimbursable to medical practice. It also markets and sells point-of-care, rapid-response diagnostic tests used in primary care practice. QHSLab offers a variety of digital healthcare intervention programs including allergies and asthma, mental health, musculoskeletal health and pain, hypertension, sleep disorders, weight loss and much more. The Company sells allergy diagnostic-related products and immunotherapy treatments to physicians.

Employees

Sector

Advanced Medical Equipment & Technology

More about the company

Quotes

Date	Price	Change	Volume
11/06/26	0.2500 $	-17.36%	12,351
09/06/26	0.3025 $	-9.70%	18,594
08/06/26	0.3350 $	-25.64%	542

Delayed Quote OTC Markets

More quotes

Income Statement and Estimates

More financial data

Market Cap	3.76M 3.25M 2.99M 2.8M 5.25M 357M 5.33M 35.32M 13.77M 174M 14.1M 13.8M 602M	P/E Ratio 2024	-8.27x	P/E Ratio 2025	30.3x
Enterprise Value	3.41M 2.95M 2.72M 2.54M 4.77M 325M 4.84M 32.09M 12.51M 158M 12.82M 12.54M 547M	EV / Sales 2024	1.97x	EV / Sales 2025	2.41x
Free-Float	51.27%	Yield 2024 *	-	Yield 2025	-

14/05	QHSLab, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
21/04	QHSLab Launches Q-Connect Glp-1 Support Assessment	CI
31/03	QHSLab, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
30/03	QHSLab, Inc. Auditor Raises 'Going Concern' Doubt	CI
26/12	QHSLab, Inc. announced that it has received $0.499999 million in funding	CI
04/12	QHSLab Inc. Announces Launch of Q-Cog to Support Early Detection of Mild Cognitive Impairment and Dementia	CI
19/11	QHSLab (OTCQB:USAQ) completes repurchase of legacy debt, enhancing capital structure, strengthening balance sheet and reducing future dilution	RE
14/11	QHSLab, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
03/09/25	QHSLab, Inc. Rolls Out Breakthrough Pediatric Screening Tool Linking Allergies and Mental Health	CI
14/08/25	QHSLab, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
08/07/25	QHSLab Inc. Opens Doors in Miami to Expand Access to Mental Health Services	CI
04/06/25	QHSLab, Inc. Publishes Peer-Reviewed Studies Validating Digital Tools for Enhancing Patient Outcomes and Healthcare Efficiency	CI
15/05/25	Qhslab Q1 Gross Margin 66.6%	RE

21/04	QHSLab (OTCQB:USAQ) Reports 127% Year-Over-Year ISP Growth and Launches Q-Connect GLP-1 Support Assessment	AQ
31/03	QHSLab (OTCQB:USAQ) Reports Strong Fiscal 2025 Results with Revenue Growth, Expanding Margins, and Significant Balance Sheet Improvement	AQ
19/02	Burnham USA Equities Retains Hanley Investment Group to Market for Sale LOCAL, a Newly Renovated and Rebranded Lifestyle Retail Center in Mission Viejo	AQ
27/01	QHSLab (OTCQB:USAQ) Reports Preliminary Unaudited 2025 Financial Results With Strong Revenue Growth, Expanding Margins, and Significant Debt Reduction	AQ
17/01	QHSLab (OTCQB:USAQ) Initiates Board Expansion Process to Strengthen Governance and Support Next Phase of Growth	AQ

1 day	-17.36%
1 week	-44.51%
Current month	-55.80%
1 month	-54.55%
3 months	-62.24%
6 months	-20.63%
Current year	-58.74%

1 week	0.25	0.34
1 month	0.25	0.57
Current year	0.25	1.14
1 year	0.08	1.14
3 years	0.02	1.14
5 years	0.02	1.14
10 years	0	1.14

QHSLab, Inc. Stock

Stocks

USAQ

US90350R1077

Advanced Medical Equipment & Technology

Valuation: QHSLab, Inc.

Chart: QHSLab, Inc.

Latest news : QHSLab, Inc.

Press Releases: QHSLab, Inc.

Quotes and Performance

Course Extremes

Managers and Directors: QHSLab, Inc.

Latest insider transactions

Other Advanced Medical Equipment & Technology

Financials

Company Profile

Quotes

Income Statement and Estimates

Manager	Title	Age	Since
Troy Grogan CEO	Chief Executive Officer	49	28/06/2016
Jeremy Jacob CTO	Chief Tech/Sci/R&D Officer	-	-
Marcos Sanchez-Gonzalez CTO	Chief Tech/Sci/R&D Officer	-	02/05/2024

Date	Insider	Type	Main position	Quantity	% Market Cap.
31/12	Troy Grogan	Others	Chief Executive Officer	1,080,092	100.0000%
31/12	Troy Grogan	Conversion	Chief Executive Officer	213,075	1.8887%
31/12	Troy Grogan	Others	Chief Executive Officer	2,644,424	100.0000%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
QHSLAB, INC.	-17.36%	-44.51%	+38.89%	+68.92%	3.76M
THERMO FISHER SCIENTIFIC, INC.	-1.33%	-0.73%	+13.00%	-10.38%	174B
INTUITIVE SURGICAL, INC.	-0.45%	-2.61%	-19.87%	+31.06%	146B
DANAHER CORPORATION	-0.38%	-2.28%	-12.19%	-24.34%	127B
BOSTON SCIENTIFIC CORPORATION	-0.55%	-3.38%	-52.40%	-8.38%	69.72B
EDWARDS LIFESCIENCES CORPORATION	-0.76%	-0.99%	+12.15%	-0.54%	49.01B
SIEMENS HEALTHINEERS AG	+0.67%	-0.60%	-25.38%	-34.31%	44.74B
AGILENT TECHNOLOGIES, INC.	+0.22%	-4.13%	+9.19%	+9.53%	36.67B
WATERS CORPORATION	-1.17%	-2.69%	+1.70%	+38.38%	34.91B
GE HEALTHCARE TECHNOLOGIES INC.	+1.04%	+0.79%	-10.85%	-16.72%	29.65B
Average	-2.01%	-1.89%	-4.58%	+5.32%	71.22B
Weighted average by Cap.	-0.55%	-1.98%	-8.84%	-1.89%

	2024	2025
Net sales	2.13M 1.84M 1.7M 1.59M 2.98M 203M 3.02M 20.04M 7.81M 98.63M 8M 7.83M 342M	2.69M 2.32M 2.14M 2.01M 3.76M 256M 3.82M 25.3M 9.86M 125M 10.1M 9.89M 431M
Net income	-259K -224K -206K -193K -362K -24.64M -368K -2.44M -950K -11.99M -973K -952K -41.53M	457K 395K 364K 341K 639K 43.48M 649K 4.3M 1.68M 21.16M 1.72M 1.68M 73.27M
Net Debt	1.58M 1.36M 1.26M 1.18M 2.2M 150M 2.24M 14.84M 5.78M 73.04M 5.93M 5.8M 253M	-343K -296K -273K -256K -479K -32.63M -487K -3.23M -1.26M -15.88M -1.29M -1.26M -54.99M